Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: Essential role of Cav3.2 channels

Cell Calcium

Volumn 56, Issue 4, 2014, Pages 285-295

  Ranzato, Elia ^a   Magnelli, Valeria ^a   Martinotti, Simona ^a   Waheed, Zeina ^b   Cain, Stuart M ^b   Snutch, Terrance P ^b   Marchetti, Carla ^c   Burlando, Bruno ^a,c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CNR   (Italy)

Author keywords

Catalase; Cav3.1; Cav3.2; Confocal Ca2+ imaging; Kv1.1; T type Ca2+ channels; Whole cell voltage clamp; Z944; Ca2+ i spike

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL T TYPE; CATALASE; CAVEOLIN 3; EPIGALLOCATECHIN GALLATE; MIBEFRADIL; POTASSIUM CHANNEL KV1.1; UNCLASSIFIED DRUG; CACNA1H PROTEIN, HUMAN; CALCIUM CHANNEL BLOCKING AGENT; CATECHIN;

ARTICLE; BREAST CANCER CELL LINE; CALCIUM CURRENT; CELL CYCLE PROGRESSION; CELL MEDIATED CYTOTOXICITY; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; GENE SILENCING; HUMAN; HUMAN CELL; ION CURRENT; MEMBRANE CURRENT; OXIDATION REDUCTION POTENTIAL; POTASSIUM CURRENT; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; VOLTAGE CLAMP TECHNIQUE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BREAST TUMOR; DRUG EFFECTS; FEMALE; MCF 7 CELL LINE; MEMBRANE POTENTIAL; METABOLISM; PATCH CLAMP TECHNIQUE; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CATECHIN; CELL LINE, TUMOR; FEMALE; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES;

EID: 84908010455     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.09.002     Document Type: Article

References (51)

1. Ciapa B., Pesando D., Wilding M., Whitaker M. Cell-cycle calcium transients driven by cyclic changes in inositol trisphosphate levels. Nature 1994, 368:875-878.
2. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
3. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 2003, 4:552-565.
4. Parkash J., Asotra K. Calcium wave signaling in cancer cells. Life Sci. 2010, 87:587-595.
5. 2+ transport. Nat. Rev. Cancer 2007, 7:519-530.
6. Triggle D.J. Calcium channel antagonists: clinical uses - past, present and future. Biochem. Pharmacol. 2007, 74:1-9.
7. Chen L., Zhang H.Y. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007, 12:946-957.
8. Shankar S., Ganapathy S., Srivastava R.K. Green tea polyphenols: biology and therapeutic implications in cancer. Front. Biosci. 2007, 12:4881-4899.
9. Chen Z.P., Schell J.B., Ho C.T., Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 1998, 129:173-179.
10. Amin A.R., Khuri F.R., Chen Z.G., Shin D.M. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB. Cancer Prev. Res. (Phila.) 2009, 2:538-545.
11. Stearns M.E., Wang M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl. Oncol. 2011, 4:147-156.
12. Wu H., Xin Y., Xu C., Xiao Y. Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Exp. Ther. Med. 2012, 3:650-654.
13. Yunos N.M., Beale P., Yu J.Q., Huq F. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Anticancer Res. 2011, 31:1131-1140.
14. Volta V., Ranzato E., Martinotti S., Gallo S., Russo M.V., Mutti L., Biffo S., Burlando B. Preclinical demonstration of synergistic active nutrients/drug (AND) combination as a potential treatment for malignant pleural mesothelioma. PLOS ONE 2013, 8:e58051.
15. Wu A.H., Yu M.C. Tea, hormone-related cancers and endogenous hormone levels. Mol. Nutr. Food Res. 2006, 50:160-169.
16. Stuart E.C., Scandlyn M.J., Rosengren R.J. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 2006, 79:2329-2336.
17. Alvarez-Castro E., Campos-Toimil M., Orallo F. (-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:496-506.
18. 2+ and partly by release of intracellular stores. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:260-267.
19. Yin S.T., Tang M.L., Deng H.M., Xing T.R., Chen J.T., Wang H.L., Ruan D.Y. Epigallocatechin-3-gallate induced primary cultures of rat hippocampal neurons death linked to calcium overload and oxidative stress. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 379:551-564.
20. 2+ channel opening. J. Cell Mol. Med. 2012, 16:2667-2678.
21. Zhang Y., Jiang X., Snutch T.P., Tao J. Modulation of low-voltage-activated T-type Ca(2+) channels. Biochim. Biophys. Acta 2012, 1828:1550-1559.
22. Taylor J.T., Zeng X.B., Pottle J.E., Lee K., Wang A.R., Yi S.G., Scruggs J.A., Sikka S.S., Li M. Calcium signaling and T-type calcium channels in cancer cell cycling. World J. Gastroenterol. 2008, 14:4984-4991.
23. Panner A., Wurster R.D. T-type calcium channels and tumor proliferation. Cell Calcium 2006, 40:253-259.
24. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 1973, 51:1409-1416.
25. Ohkubo T., Yamazaki J. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. Int. J. Oncol. 2012, 41:267-275.
26. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett. 2008, 267:116-124.
27. Bertolesi G.E., Shi C., Elbaum L., Jollimore C., Rozenberg G., Barnes S., Kelly M.E. The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol. Pharmacol. 2002, 62:210-219.
28. Tringham E., Powell K.L., Cain S.M., Kuplast K., Mezeyova J., Weerapura M., Eduljee C., Jiang X., Smith P., Morrison J.L., Jones N.C., Braine E., Rind G., Fee-Maki M., Parker D., Pajouhesh H., Parmar M., O'Brien T.J., Snutch T.P. T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures. Sci. Transl. Med. 2012, 4:121ra19.
29. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
30. Marchetti C., Gavazzo P. Subunit-dependent effects of nickel on NMDA receptor channels. Brain Res. Mol. Brain Res. 2003, 117:139-144.
31. Belardetti F., Tringham E., Eduljee C., Jiang X., Dong H., Hendricson A., Shimizu Y., Janke D.L., Parker D., Mezeyova J., Khawaja A., Pajouhesh H., Fraser R.A., Arneric S.P., Snutch T.P. A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers. Assay Drug Dev. Technol. 2009, 7:266-280.
32. Barnes M., Correll R., Stevens D. A simple spreadsheet for estimating low-effect concentrations and associated logistic dose response curves. Solutions to Pollution: Program Abstract Book 2003, SETAC ASE Asia Pacific. A. The Society of Environmental Toxicology and Chemistry (Ed.).
33. Donnadieu E., Bismuth G., Trautmann A. Calcium fluxes in T lymphocytes. J. Biol. Chem. 1992, 267:25864-25872.
34. 2+ entry in cancer cells. Cell Calcium 2004, 36:489-497.
35. Ouadid-Ahidouch H., Chaussade F., Roudbaraki M., Slomianny C., Dewailly E., Delcourt P., Prevarskaya N. KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem. Biophys. Res. Commun. 2000, 278:272-277.
36. Hsuuw Y.D., Chan W.H. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann. N. Y. Acad. Sci. 2007, 1095:428-440.
37. Li W., Zhang S.L., Wang N., Zhang B.B., Li M. Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. Cancer Invest. 2011, 29:339-346.
38. 2+ release from ryanodine receptors in rat spiral ganglion neurons. Cell Calcium 2008, 43:356-366.
39. Jeong H.S., Jang S., Jang M.J., Lee S.G., Kim T.S., Tag H., Lee J.H., Jun J.Y., Park J.S. Effects of (-)-epigallocatechin-3-gallate on the activity of substantia nigra dopaminergic neurons. Brain Res. 2007, 1130:114-118.
40. Choi B.H., Choi J.S., Min D.S., Yoon S.H., Rhie D.J., Jo Y.H., Kim M.S., Hahn S.J. Effects of (-)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels. Biochem. Pharmacol. 2001, 62:527-535.
41. Jeong H.S., Kim Y.S., Park J.S. Modulation of neuronal activity by EGCG. Brain Res. 2005, 1047:267-270.
42. Elbling L., Weiss R.M., Teufelhofer O., Uhl M., Knasmueller S., Schulte-Hermann R., Berger W., Micksche M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 2005, 19:807-809.
43. Chan M.M., Soprano K.J., Weinstein K., Fong D. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J. Cell Physiol. 2006, 207:389-396.
44. + channels are regulated by mitochondria-derived hydrogen peroxide. Biol. Chem. 2004, 385:205-216.
45. Umeda D., Yano S., Yamada K., Tachibana H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J. Biol. Chem. 2008, 283:3050-3058.
46. Fujimura Y., Sumida M., Sugihara K., Tsukamoto S., Yamada K., Tachibana H. Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor. PLOS ONE 2012, 7:e37942.
47. Martignone S., Menard S., Bufalino R., Cascinelli N., Pellegrini R., Tagliabue E., Andreola S., Rilke F., Colnaghi M.I. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J. Natl. Cancer Inst. 1993, 85:398-402.
48. Menard S., Castronovo V., Tagliabue E., Sobel M.E. New insights into the metastasis-associated 67kD laminin receptor. J. Cell Biochem. 1997, 67:155-165.
49. Hou Z., Sang S., You H., Lee M.J., Hong J., Chin K.V., Yang C.S. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005, 65:8049-8056.
50. Lin H.Y., Hou S.C., Chen S.C., Kao M.C., Yu C.C., Funayama S., Ho C.T., Way T.D. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. J. Agric. Food Chem. 2012, 60:2480-2489.
51. Singh T., Katiyar S.K. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting beta-catenin signaling. Toxicol. Appl. Pharmacol. 2013, 273:418-424.